News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|January 23, 2025

Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

Panelists discuss how they envision the future of industry-provided and other patient support services in hematology-oncology, highlighting potential improvements and innovations that could be implemented in the near future.

Episodes in this series

EP. 1 Challenges at Diagnosis: Navigating the Emotional and Physical Realities of DLBCL and FL

EP. 1 Challenges at Diagnosis: Navigating the Emotional and Physical Realities of DLBCL and FL

EP. 2 Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care

EP. 2 Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care

EP. 3 Tailored Support: The Role of Industry-Provided Services in Lymphoma Care

EP. 3 Tailored Support: The Role of Industry-Provided Services in Lymphoma Care

EP. 4 Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

EP. 4 Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

EP. 5 Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

EP. 5 Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

Video content above is prompted by the following:

What do you think is the future of industry-provided and other patient support services in hematology-oncology, and what improvements or innovations would you like to see implemented in the near future?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

From Weight Loss to Liver Normalization: A Deep Dive Into the SYNCHRONIZE-1 Trial Results

ByMazen Noureddin, MD, MHSc

August 7th 2026

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

ByMazen Noureddin, MD, MHSc

August 7th 2026

The Primary Care Gap in MASH: Understanding Screening Barriers and the Path to Better Detection

ByMazen Noureddin, MD, MHSc

July 31st 2026

Why Body Surface Area Alone Doesn't Capture Vitiligo Severity

ByRyan Haumschild, PharmD, MBA,David Rosmarin, MD,Seemal R. Desai, MD, FAAD,Jason Fehr, MA,Karan Lal, DO, MS, FAAD

July 31st 2026

The Obesity-MASH Burden: What the Numbers Tell Us and How to Screen More Effectively

ByMazen Noureddin, MD, MHSc

July 31st 2026

Trending on AJMC

Trump Childhood Vaccine Order: What It Means for Parents and Payers

FDA Proposes GRAS Rule, Advances Ultra-Processed Food Definition

Access, Coverage, and Final Reflections on Managing Alzheimer's Disease Agitation

Orelabrutinib Cuts Progression Risk 68% in Frontline CLL/SLL

Extreme Heat May Increase Microplastic Exposure, Related Health Concerns: Eva R. Parker, MD